Estimation of infarct size by single measurements of creatine kinase levels in patients with a first myocardial infarction

J Cardiovasc Med (Hagerstown). 2006 May;7(5):340-6. doi: 10.2459/01.JCM.0000223256.01439.1b.

Abstract

Objective: Enzymatic estimation of infarct size is desirable in the reperfusion era, because a possible discrepancy with the observed asynergic area of the left ventricle may suggest the presence of stunned myocardium. Unfortunately, timely myocardial reperfusion produces a rapid washout of creatine kinase (CK) in blood flow, which overestimates infarct size. In this perspective, we investigated whether the mid-terminal portion of the CK time-activity curve could predict infarct size more reliably.

Methods: Enzymatic infarct size was calculated by peak CK levels, the CK area under the curve and by single CK values, in 103 patients with a first ST-elevation myocardial infarction, and compared to the left ventricular akinetic area. The wall motion asynergy score at follow-up was considered as the actual infarct size.

Results: In patients with peak CK within 10 h of symptom onset, CK levels at 30 h showed a high independent correlation (r = 0.83; P < 0.001) with infarct size. In patients with late peak CK (> 10 h), CK levels at 12 h turned out to be the best predictor of infarct size (r = 0.55; P < 0.01). At multivariate regression analysis, peak CK was the best predictor of infarct size in the whole population (r = 0.61; P < 0.001).

Conclusions: In patients with ST-elevation myocardial infarction and early peak CK, infarct size at follow-up could be better estimated with single values of the mid-terminal portion of the CK time-activity curve.

MeSH terms

  • Aged
  • Analysis of Variance
  • Angioplasty, Balloon, Coronary
  • Area Under Curve
  • Biomarkers / blood
  • Creatine Kinase / blood*
  • Echocardiography
  • Female
  • Follow-Up Studies
  • Humans
  • Italy
  • Logistic Models
  • Male
  • Middle Aged
  • Myocardial Infarction / enzymology*
  • Myocardial Infarction / pathology*
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / therapy
  • Myocardial Reperfusion
  • Predictive Value of Tests
  • Research Design
  • Retrospective Studies
  • Stroke Volume
  • Thrombolytic Therapy
  • Time Factors
  • Ventricular Dysfunction, Left / enzymology*
  • Ventricular Dysfunction, Left / pathology*
  • Ventricular Dysfunction, Left / physiopathology
  • Ventricular Dysfunction, Left / therapy

Substances

  • Biomarkers
  • Creatine Kinase